Cohance Lifesciences P/B Ratio
Cohance Lifesciences (COHANCE) P/B ratio is 4.35 (High), book value per share ₹1029.21 vs Healthcare average P/B of -0.67 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Cohance Lifesciences share price screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
COHANCE P/B Ratio — Valuation Insights & Book Value Analysis
Cohance Lifesciences price-to-book ratio interpretation, valuation status and historical context — current P/B 4.35 (High). Compare with Cohance Lifesciences valuation methods to assess whether the stock is under or overvalued.
- Stock appears overvalued with PB of 4.35, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 381.2% above historical average
- Trading at premium to sector average PB of -0.67
Cohance Lifesciences P/B Ratio Historical Trend
COHANCE annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View COHANCE yearly price range for the annual high/low range and current price position.
COHANCE Historical P/B Ratio — Book Value Per Share & Year-End Price
Cohance Lifesciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.41 | ₹1029.21 | ₹418.55 | ₹3,911 | Low |
| 2025 | 0.75 | ₹708.08 | ₹528.60 | ₹1,841 | Low |
| 2024 | 1.44 | ₹788.85 | ₹1138.75 | ₹2,051 | Moderate |
| 2023 | 1.08 | ₹667.31 | ₹722.80 | ₹1,735 | Moderate |
| 2022 | 0.84 | ₹587.31 | ₹494.90 | ₹1,527 | Low |
COHANCE vs Healthcare Peers — P/B Ratio Comparison
Cohance Lifesciences P/B 4.35 vs Healthcare average -0.67, median 0.6 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |